Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
MC1R activation by MT-1 drives cAMP-PKA signalling that upregulates nucleotide excision repair enzymes, reduces cyclobutane pyrimidine dimer formation following UV challenge, activates antioxidant defence pathways, and suppresses UV-induced inflammatory cytokine production through NF-B inhibition
Mapping the glutathione-binding site
Retrieved 1 June 2014
Combination therapies Combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists offers a promising approach to enhance cardiovascular and kidney protection in people with type 2 diabetes mellitus, particularly those at high risk [9,20]
US$ 22.75
US$ 29.34
US$ 29.21
US$ 23.54
US$ 28.17
